2018 欧洲专家共识:临床应用富马酸二甲酯治疗中重度斑块型银屑病

2018-09-20 欧洲皮肤病与性病学会 J Eur Acad Dermatol Venereol. 2018 Sep 20.

富马酸酯类药物于1959年首次用于治疗银屑病,本文主要针对临床应用富马酸二甲酯治疗中重度斑块型银屑病的相关内容提出指导建议,涉及患者的选择,考虑用药剂量,监测以及副作用管理等。

中文标题:

2018 欧洲专家共识:临床应用富马酸二甲酯治疗中重度斑块型银屑病

英文标题:

Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus

发布日期:

2018-09-20

简要介绍:

富马酸酯类药物于1959年首次用于治疗银屑病,本文主要针对临床应用富马酸二甲酯治疗中重度斑块型银屑病的相关内容提出指导建议,涉及患者的选择,考虑用药剂量,监测以及副作用管理等。
 
拓展指南:银屑病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 欧洲专家共识:临床应用富马酸二甲酯治疗中重度斑块型银屑病)] GetToolGuiderByIdResponse(projectId=1, id=d00ce1c0016a4e35, title=2018 欧洲专家共识:临床应用富马酸二甲酯治疗中重度斑块型银屑病, enTitle=Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus, guiderFrom=J Eur Acad Dermatol Venereol. 2018 Sep 20., authorId=null, author=, summary=富马酸酯类药物于1959年首次用于治疗银屑病,本文主要针对临床应用富马酸二甲酯治疗中重度斑块型银屑病的相关内容提出指导建议,涉及患者的选择,考虑用药剂量,监测以及副作用管理等。 , cover=, journalId=null, articlesId=null, associationId=1016, associationName=欧洲皮肤病与性病学会, associationIntro=EADV is a non-profit association, founded in 1987, whose mission is to advance excellence in clinical care, research, education and training in the field of dermatology and Venereology and to act as the advocate and educator of patients particularly those with cutaneous or venereal diseases., copyright=0, guiderPublishedTime=Thu Sep 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>富马酸酯类药物于1959年首次用于治疗银屑病,本文主要针对临床应用富马酸二甲酯治疗中重度斑块型银屑病的相关内容提出指导建议,涉及患者的选择,考虑用药剂量,监测以及副作用管理等。</div> <div> </div>拓展指南:<strong>与<font color=red>银屑病</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2ab7c1c0016a3430" title="2018 JDA指南:泛发性脓疱型银屑病的管理和治疗" target=_blank>2018 JDA指南:泛发性脓疱型银屑病的管理和治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d99c21c00161a021" title="皮肤科分会银屑病中医治疗专家共识(2017年版)" target=_blank>皮肤科分会银屑病中医治疗专家共识(2017年版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e39511c0015908dc" title="2018 亚洲共识:轻中度斑块型银屑病局部治疗的评估和管理" target=_blank>2018 亚洲共识:轻中度斑块型银屑病局部治疗的评估和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=87c6f1c0015501e5" title="寻常型银屑病中医外治特色疗法专家共识(2017年)" target=_blank>寻常型银屑病中医外治特色疗法专家共识(2017年)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=029041c0015309c9" title="中轴及外周型脊柱关节炎(尤其是银屑病关节炎)的达标治疗:国际工作组推荐2017年更新" target=_blank>中轴及外周型脊柱关节炎(尤其是银屑病关节炎)的达标治疗:国际工作组推荐2017年更新</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%93%B6%E5%B1%91%E7%97%85" target=_blank>有关银屑病更多指南</a></ul>, tagList=[TagDto(tagId=9923, tagName=富马酸二甲酯), TagDto(tagId=26991, tagName=斑块型银屑病)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6442, appHits=139, showAppHits=0, pcHits=4797, showPcHits=2486, likes=126, shares=4, comments=2, approvalStatus=1, publishedTime=Sat Sep 29 20:47:45 CST 2018, publishedTimeString=2018-09-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Sep 29 20:47:45 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 02:58:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 欧洲专家共识:临床应用富马酸二甲酯治疗中重度斑块型银屑病)])
2018 欧洲专家共识:临床应用富马酸二甲酯治疗中重度斑块型银屑病
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195365, encodeId=f8dd1195365e1, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Sun Feb 20 15:24:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347278, encodeId=d0e134e27884, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 29 21:57:17 CST 2018, time=2018-09-29, status=1, ipAttribution=)]
    2022-02-20 屋顶瞄爱赏月

    学习学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195365, encodeId=f8dd1195365e1, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Sun Feb 20 15:24:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347278, encodeId=d0e134e27884, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 29 21:57:17 CST 2018, time=2018-09-29, status=1, ipAttribution=)]
    2018-09-29 医者仁心5538

    学习了

    0